HealthNet - All plan years
Skyrizi (Syrg) (risankizumab-rzaa)
Drugs for the Skin : Drugs for the Skin
  • Oral Anti-Cancer drug
  • Step Therapy: Systemic Anaplastic Large Cell Lymphoma:
    ST Multiple Generics

  • Quantity Limit: 30 day supply per 1 fill(s).